PIMREG: A Promising Drug Target / Biomarker (G54478)

Target Name: PIMREG

NCBI ID: G54478

PIMREG

PIMREG: A Promising Drug Target / Biomarker

PIMREG is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of the immune response and has been implicated in a number of diseases, including neurodegenerative disorders, autoimmune diseases, and cancer. Despite its importance, much is still not known about PIMREG and its role in the body.

The protein PIMREG is a member of the IMP-2 (inositol-dependent protein kinase) family, which is characterized by the presence of a catalytic 伪-heme and a regulatory 尾-sheet. PIMREG is unique in that it contains both an 伪-heme and a 尾-sheet, which suggests that it has a unique structure and function.

PIMREG and the Immune Response

PIMREG is involved in the immune response by regulating the production and activation of T cells. T cells are a critical component of the immune system and play a key role in fighting off infections and diseases. PIMREG is regulated by the immune response by several mechanisms, including the T-cell receptor (TCR) and the B-cell receptor (BCR).

PIMREG has been shown to play a role in the regulation of T-cell development and activation. It has been shown to promote the expansion and maturation of T-cells, and to regulate the expression of genes that are important for T-cell activation and proliferation.

PIMREG is also involved in the regulation of the immune response by controlling the production of antibodies. PIMREG has been shown to regulate the production of antibodies by B cells, and to play a role in the regulation of antibody class switching.

PIMREG and Neurodegenerative Disorders

PIMREG is also involved in the development and progression of neurodegenerative disorders. Neurodegenerative disorders are a group of diseases that are characterized by the progressive loss of brain cells and the development of debilitating symptoms. PIMREG has been implicated in the development and progression of several neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

PIMREG is shown to play a role in the regulation of neurodegenerative disorders by regulating the production and activation of T cells. T cells are a critical component of the immune system and have been implicated in the development and progression of neurodegenerative disorders. PIMREG has been shown to regulate the production of T cells by controlling the production of CD4+ T cells, which are a critical subset of the immune system.

PIMREG is also involved in the regulation of neurodegenerative disorders by regulating the production of antibodies. antibodies are produced by B cells and play a critical role in the immune response. PIMREG has been shown to regulate the production of antibodies by B cells, and to play a role in the regulation of antibody class switching.

PIMREG and Autoimmune Diseases

PIMREG is also involved in the development and progression of autoimmune diseases. Autoimmune diseases are a group of diseases in which the immune system attacks the body's own tissues and causes inflammation and damage. PIMREG has been implicated in the development and progression of autoimmune diseases by regulating the production and activation of T cells. T cells are a critical component of the immune system and have been shown to play a key role in the development and progression of autoimmune diseases.

PIMREG is shown to play a role in the regulation of autoimmune diseases by regulating the production of T cells. T cells are a critical component of the immune system and have been implicated in the development and progression of autoimmune diseases. PIMREG has been shown to regulate the production of T cells by controlling the production of CD4+ T cells, which are a critical subset of the immune system.

PIMREG and Cancer

PIMREG is also involved in the development and progression of cancer. Cancer is a group of diseases

Protein Name: PICALM Interacting Mitotic Regulator

Functions: During mitosis, may play a role in the control of metaphase-to-anaphase transition

The "PIMREG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIMREG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets